Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).
Annals of Oncology.
Times cited: 7
- A new intensified therapeutic regimen for advanced head and neck squamous cell carcinomas: Where does it fit among available treatment options?. Cancer Investigation. 2001 Editorial Article GET IT
Clinical economics of head and neck malignancies.
Hematology/Oncology Clinics of North America.
Times cited: 6